Business Model Breakdown
How Aehr Test Systems Makes Money
AEHR
Market Cap
$2.9B
Annual Revenue
$59M
Profit Margin
-25.2%
The Short Version
Aehr Test Systems designs, manufactures, and sells advanced burn-in and test systems used for the mass production and reliability qualification of semiconductor devices. Their primary revenue comes from selling these specialized equipment solutions, particularly their ABTSTM and FOX-PFTM platforms, which are critical for testing next-generation AI processors, memory, and silicon photonics devices for data centers and other high-performance computing applications. The company also generates revenue from maintenance and service contracts. They operate in a niche but highly critical segment of the semiconductor supply chain, providing essential tools to ensure the reliability and performance of complex chips before deployment.
Where the Revenue Comes From
Sale of ABTSTM and FOX-PFTM burn-in and test systems (~85-90% of revenue)
Services and spare parts (~10-15% of revenue)
Who buys: Semiconductor manufacturers (foundries, IDMs), Outsourced Semiconductor Assembly and Test (OSAT) providers, and increasingly direct to hyperscale cloud providers developing custom AI chips.
Why It Works (Competitive Advantages)
- ✔Proprietary burn-in and test technology (e.g., FOX-PFTM) optimized for high-performance and high-volume applications.
- ✔First-mover advantage and specialized expertise in critical AI and silicon photonics device reliability testing.
- ✔Strong relationships with hyperscale cloud customers for custom AI chips.
Economic Moat: Narrow (Intangible Assets/IP, Switching Costs, Efficient Scale)
What Our Analysis Says
DVR Score as of April 21, 2026
Aehr Test Systems' score has increased due to significant execution on its strategic pivot into AI and silicon photonics burn-in markets. The recent record $41 million AI production order from a hyperscale cloud customer, coupled with Q3 FY26's strong $37.2 million bookings (book-to-bill >3.5x) and raised FY26 guidance, strongly validates its future growth trajectory and market leadership potential in a critical niche. While Q3 FY26 showed unprofitability and a revenue miss, and the $60 million ATM offering caused dilution, the substantial order wins and strengthened balance sheet (post-ATM) outweigh these for the long-term 10x growth thesis. The elevated valuation (P/S ~52.8x) and a cluster of insider sales are noted red flags, but the material new orders significantly de-risk future revenue visibility, warranting a higher conviction score.